Faeth Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Faeth Therapeutics, Inc. (FTH) reported Increase (Decrease) in Prepaid Expense and Other Assets of $125.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2021-11-10
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-09-30 was -$1.61M.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-06-30 was -$252.00K.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-03-31 was $1.99M, a 138.85% increase year-over-year.
- Faeth Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-09-30 was -$384.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|---|
| 2021-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.87M derived: sum of 2 quarters · filed 2021-11-10 | $125.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.74M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $1.99M 10-Q · filed 2021-05-13 | ||
| 2020-09-30 | -$384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$389.00K derived: sum of 2 quarters · filed 2021-11-10 | $445.00K 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $829.00K 10-Q · filed 2021-08-11 | |
| 2020-03-31 | $834.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |